HC Wainwright reiterated their buy rating on shares of CG Oncology (NASDAQ:CGON - Free Report) in a report issued on Thursday, Benzinga reports. HC Wainwright currently has a $75.00 target price on...
CG Oncology (NASDAQ:CGON - Get Free Report)s stock had its "buy" rating reiterated by stock analysts at HC Wainwright in a research note issued to investors on Thursday, Benzinga reports. They...
- New 12-month data from the Phase 3 BOND-003 trial to be featured in an oral presentation in the Paradigm-shifting, Practice-changing Clinical Trials in Urology plenary session -IRVINE, Calif...
Shares of CG Oncology, Inc. (NASDAQ:CGON Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $39.70, but opened at $38.90. CG Oncology...